Skip to main content

What the FDA labels say about taking them together

Exemestane and phenobarbital

Exemestane's FDA label of September 12, 2024 names phenobarbital in its drug interactions section; the phenobarbital labels PlainMeds reads (2) do not name exemestane. The exemestane label: “Drugs That Induce CYP 3A4 Co-medications that induce CYP 3A4 may significantly decrease exposure to exemestane.”

Check it at the source: the exemestane FDA label on DailyMed (effective September 12, 2024, Breckenridge Pharmaceutical, Inc.); the phenobarbital FDA label on DailyMed (effective August 27, 2026).

What does the exemestane label say about phenobarbital?

Exemestane label, drug interactions

Drugs That Induce CYP 3A4 Co-medications that induce CYP 3A4 (e.g., rifampicin, phenytoin, carbamazepine, phenobarbital, or St. John's Wort) may significantly decrease exposure to exemestane.

Source: FDA drug label (Exemestane), Breckenridge Pharmaceutical, Inc., effective September 12, 2024 (SPL set 4e3fd382-19f5-4ded-ab22-39d5b1b2f366), via openFDA; the full label on DailyMed

What does the phenobarbital label say about exemestane?

Phenobarbital's label (effective August 27, 2026) and its 1 other brand-application label do not name exemestane in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Phenobarbital), Chartwell RX, LLC, effective August 27, 2026 (SPL set 74428144-fb24-40a5-a670-3b876e2d116c), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

10Exemestane generic labelers
0Phenobarbital generic labelers
ExemestanePhenobarbital
Labeled forBreast cancerSeizures and epilepsy
Boxed warningNoNo
Pharmacy cost (NADAC)$0.748 per tablet 25 mg tablet$0.213 per tablet 100 mg tablet
Shortage nowNo current entryA presentation being discontinued

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?